This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kita, E.
Right arrow Articles by Higashi, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kita, E.
Right arrow Articles by Higashi, N.

 Previous Article  |  Next Article 

Infection and Immunity, March 2000, p. 1207-1214, Vol. 68, No. 3
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Pathogenic Mechanism of Mouse Brain Damage Caused by Oral Infection with Shiga Toxin-Producing Escherichia coli O157:H7

Eiji Kita,1,* Yoshihisa Yunou,1 Takaaki Kurioka,1 Hiroko Harada,1 Shinji Yoshikawa,1 Keiichi Mikasa,2 and Nobutaka Higashi1

Department of Bacteriology1 and Department of Medicine II,2 Nara Medical University, Kashihara, Nara 634-8521, Japan

Received 1 October 1999/Returned for modification 29 October 1999/Accepted 12 November 1999

In a previous study, we showed that infection with Shiga toxin (Stx)-producing Escherichia coli O157:H7 (strain SmrN-9) caused neurologic symptoms in malnourished mice with positive immunoreactions of Stx2 in brain tissues. The present study explores the mechanism of how Stx injures the vascular endothelium to enter the central nervous system in mice. Oral infection with strain SmrN-9 elicited a tumor necrosis factor alpha (TNF-alpha ) response in the blood as early as 2 days after infection, while Stx was first detected at 3 days postinfection. In the brain, TNF-alpha was detected at day 3, and its quantity was increased over the next 3 days. Frozen sections of the brains from moribound mice contained high numbers of apoptotic cells. Glycolipids recognized by an anti-Gb3 monoclonal antibody were extracted from the brain, and purified Stx2 was able to bind to the glycolipids. In human umbilical vascular endothelial cells (HUVEC) cultured with fluorescein-labeled Stx2 (100 ng/ml), TNF-alpha (20 U/ml) significantly facilitated the intracellular compartmentalization of fluorescence during 24 h of incubation, suggesting the enhanced intracellular processing of Stx2. Consequently, higher levels of apoptosis in HUVEC were found at 48 h. Short-term exposure of HUVEC to Stx2 abrogated their apoptotic response to subsequent incubation with TNF-alpha alone or TNF-alpha and Stx2. In contrast, primary exposure of HUVEC to TNF-alpha followed by exposure to Stx2 alone or TNF-alpha and Stx2 induced apoptosis at the same level as obtained after 48-h incubation with these two agents. These results suggest that the rapid production of circulating TNF-alpha after infection induces a state of competence in vascular endothelial cells to undergo apoptosis, which would be finally achieved by subsequent elevation of Stx in the blood. In this synergistic action, target cells must be first exposed to TNF-alpha . Such cell injury may be a prerequisite to brain damage after infection with Stx-producing E. coli O157:H7.


* Corresponding author. Mailing address: Department of Bacteriology, Nara Medical University, 840, Shijyocho, Kashihara, Nara 634-8521, Japan. Phone: 81-744-29-8839. Fax: 81-744-29-7375. E-mail: eijikita{at}nmu-gw.cc.naramed-u.ac.jp.


Infection and Immunity, March 2000, p. 1207-1214, Vol. 68, No. 3
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Sauter, K. A. D., Melton-Celsa, A. R., Larkin, K., Troxell, M. L., O'Brien, A. D., Magun, B. E. (2008). Mouse Model of Hemolytic-Uremic Syndrome Caused by Endotoxin-Free Shiga Toxin 2 (Stx2) and Protection from Lethal Outcome by Anti-Stx2 Antibody. Infect. Immun. 76: 4469-4478 [Abstract] [Full Text]  
  • Nishikawa, K., Watanabe, M., Kita, E., Igai, K., Omata, K., Yaffe, M. B., Natori, Y. (2006). A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin. FASEB J. 20: 2597-2599 [Abstract] [Full Text]  
  • Viebig, N. K., Wulbrand, U., Forster, R., Andrews, K. T., Lanzer, M., Knolle, P. A. (2005). Direct Activation of Human Endothelial Cells by Plasmodium falciparum-Infected Erythrocytes. Infect. Immun. 73: 3271-3277 [Abstract] [Full Text]  
  • Fujii, J., Matsui, T., Heatherly, D. P., Schlegel, K. H., Lobo, P. I., Yutsudo, T., Ciraolo, G. M., Morris, R. E., Obrig, T. (2003). Rapid Apoptosis Induced by Shiga Toxin in HeLa Cells. Infect. Immun. 71: 2724-2735 [Abstract] [Full Text]  
  • Yuhas, Y., Weizman, A., Ashkenazi, S. (2003). Bidirectional Concentration-Dependent Effects of Tumor Necrosis Factor Alpha in Shigella dysenteriae-Related Seizures. Infect. Immun. 71: 2288-2291 [Abstract] [Full Text]  
  • Imai, Y., Fukui, T., Kurohane, K., Miyamoto, D., Suzuki, Y., Ishikawa, T., Ono, Y., Miyake, M. (2003). Restricted Expression of Shiga Toxin Binding Sites on Mucosal Epithelium of Mouse Distal Colon. Infect. Immun. 71: 985-990 [Abstract] [Full Text]  
  • Nishikawa, K., Matsuoka, K., Kita, E., Okabe, N., Mizuguchi, M., Hino, K., Miyazawa, S., Yamasaki, C., Aoki, J., Takashima, S., Yamakawa, Y., Nishijima, M., Terunuma, D., Kuzuhara, H., Natori, Y. (2002). A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7. Proc. Natl. Acad. Sci. USA 99: 7669-7674 [Abstract] [Full Text]  
  • Tarr, P. I. (2002). Basic Fibroblast Growth Factor and Shiga Toxin-O157:H7-Associated Hemolytic Uremic Syndrome. J. Am. Soc. Nephrol. 13: 817-820 [Full Text]